These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 25963186)

  • 1. Transperineal Template Guided Prostate Biopsy Selects Candidates for Active Surveillance--How Many Cores are Enough?
    Pham KN; Porter CR; Odem-Davis K; Wolff EM; Jeldres C; Wei JT; Morgan TM
    J Urol; 2015 Sep; 194(3):674-9. PubMed ID: 25963186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transperineal Template-guided Mapping Biopsy Identifies Pathologic Differences Between Very-Low-risk and Low-risk Prostate Cancer: Implications for Active Surveillance.
    Merrick GS; Delatore A; Butler WM; Bennett A; Fiano R; Anderson R; Adamovich E
    Am J Clin Oncol; 2017 Feb; 40(1):53-59. PubMed ID: 25068472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of early transperineal template-guided prostate biopsy for risk stratification in men undergoing active surveillance for prostate cancer.
    Voss J; Pal R; Ahmed S; Hannah M; Jaulim A; Walton T
    BJU Int; 2018 Jun; 121(6):863-870. PubMed ID: 29239082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of transperineal template prostate biopsies in restaging men with prostate cancer managed by active surveillance.
    Ayres BE; Montgomery BS; Barber NJ; Pereira N; Langley SE; Denham P; Bott SR
    BJU Int; 2012 Apr; 109(8):1170-6. PubMed ID: 21854535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of prostate biopsy in patients considered for active surveillance. The role of the confirmatory biopsy and transperineal techniques.
    Fernandez Gomez JM; Garcia Rodriguez J
    Arch Esp Urol; 2014 Jun; 67(5):409-18. PubMed ID: 24914840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transperineal template-guided prostate biopsy for patients with persistently elevated PSA and multiple prior negative biopsies.
    Gershman B; Zietman AL; Feldman AS; McDougal WS
    Urol Oncol; 2013 Oct; 31(7):1093-7. PubMed ID: 22305626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transperineal template-guided saturation biopsy aimed at sampling one core for each milliliter of prostate volume: 103 cases requiring repeat prostate biopsy.
    Nakai Y; Tanaka N; Anai S; Miyake M; Hori S; Tatsumi Y; Morizawa Y; Fujii T; Konishi N; Fujimoto K
    BMC Urol; 2017 Apr; 17(1):28. PubMed ID: 28381267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transperineal Prostate Biopsy Improves the Detection of Clinically Significant Prostate Cancer among Men on Active Surveillance.
    Meyer AR; Mamawala M; Winoker JS; Landis P; Epstein JI; Macura KJ; Allaf ME; Partin AW; Pavlovich CP; Gorin MA
    J Urol; 2021 Apr; 205(4):1069-1074. PubMed ID: 33487007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical utility of transperineal template-guided saturation prostate biopsy for risk stratification after transrectal ultrasound-guided biopsy.
    Song W; Kang M; Jeong BC; Seo SI; Jeon SS; Lee HM; Jeon HG
    Investig Clin Urol; 2019 Nov; 60(6):454-462. PubMed ID: 31692988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical performance of transperineal template guided mapping biopsy for therapeutic decision making in low risk prostate cancer.
    Ahallal Y; Sanchez-Salas R; Sivaraman A; Barret E; Secin FP; Validire P; Rozet F; Galiano M; Cathelineau X
    Actas Urol Esp; 2016 Dec; 40(10):615-620. PubMed ID: 27527686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Performance of Initial Transperineal Template-guided Mapping Biopsy of the Prostate Gland.
    Bittner N; Merrick GS; Bennett A; Butler WM; Andreini HJ; Taubenslag W; Adamovich E
    Am J Clin Oncol; 2015 Jun; 38(3):300-3. PubMed ID: 23764680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Location in Upgrading and Detection after Transperineal Template-Guided Mapping Biopsy for Patients in Active Surveillance and Negative Transrectal Ultrasonography-Guided Prostate Biopsy.
    Lee CU; Sung SH; Jang CT; Kang M; Sung HH; Jeong BC; Seo SI; Jeon SS; Lee HM; Jeon HG
    Urol Int; 2019; 103(3):262-269. PubMed ID: 31269509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial Experience Performing In-office Ultrasound-guided Transperineal Prostate Biopsy Under Local Anesthesia Using the PrecisionPoint Transperineal Access System.
    Meyer AR; Joice GA; Schwen ZR; Partin AW; Allaf ME; Gorin MA
    Urology; 2018 May; 115():8-13. PubMed ID: 29409845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regular transition zone biopsy during active surveillance for prostate cancer may improve detection of pathological progression.
    Wong LM; Toi A; Van der Kwast T; Trottier G; Alibhai SM; Timilshina N; Evans A; Zlotta A; Fleshner N; Finelli A
    J Urol; 2014 Oct; 192(4):1088-93. PubMed ID: 24742593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection rate for significant cancer at confirmatory biopsy in men enrolled in Active Surveillance protocol: 20 cores vs 30 cores vs MRI/TRUS fusion prostate biopsy.
    Pepe P; Cimino S; Garufi A; Priolo G; Russo GI; Giardina R; Reale G; Barbera M; Panella P; Pennisi M; Morgia G
    Arch Ital Urol Androl; 2016 Dec; 88(4):300-303. PubMed ID: 28073197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High detection rate of significant prostate tumours in anterior zones using transperineal ultrasound-guided template saturation biopsy.
    Mabjeesh NJ; Lidawi G; Chen J; German L; Matzkin H
    BJU Int; 2012 Oct; 110(7):993-7. PubMed ID: 22394668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How many cores are enough? Optimizing the transperineal prostate biopsy template.
    Schaufler C; Daigle R; Singhaviranon S; Gjertson CK; Albertsen PC; Ristau BT
    Urol Oncol; 2022 May; 40(5):191.e1-191.e7. PubMed ID: 35067430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and pathological features of prostate cancer detected on transperineal template guided mapping biopsy after negative transrectal ultrasound guided biopsy.
    Bittner N; Merrick GS; Butler WM; Bennett A; Galbreath RW
    J Urol; 2013 Aug; 190(2):509-14. PubMed ID: 23416641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological upgrading in prostate cancer patients eligible for active surveillance: Does prostate-specific antigen density matter?
    Jin BS; Kang SH; Kim DY; Oh HG; Kim CI; Moon GH; Kwon TG; Park JS
    Korean J Urol; 2015 Sep; 56(9):624-9. PubMed ID: 26366274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transperineal magnetic resonance image targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancer.
    Kasivisvanathan V; Dufour R; Moore CM; Ahmed HU; Abd-Alazeez M; Charman SC; Freeman A; Allen C; Kirkham A; van der Meulen J; Emberton M
    J Urol; 2013 Mar; 189(3):860-6. PubMed ID: 23063807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.